Female Reproductive Disorders - Comprehensive Study Guide

Key Terms
  • Menarche: The first occurrence of menstruation, typically occurring between ages 1010 and 1616.

  • Dysmenorrhea: Painful menstruation, often involving abdominal cramps.

  • Dyspareunia: Difficult or painful sexual intercourse.

  • Adnexa: The appendages of the uterus, namely the ovaries and fallopian tubes.

  • Amenorrhea: The absence of menstruation; primary (never started by age 1616) or secondary (stopped for 33 to 66 months).

  • Metrorrhagia: Bleeding between regular menstrual periods.

  • Menorrhagia: Excessive menstrual bleeding in duration or amount (>80\text{ mL} per cycle).

  • Infertility: The inability to conceive after 1212 months of regular unprotected sexual intercourse (66 months for women over 3535).

Anatomy and Physiology: Hormonal Regulation
  • Hypothalamic-Pituitary-Ovarian Axis:

    • Gonadotropin-Releasing Hormone (GnRH): Released by the hypothalamus to stimulate the anterior pituitary.

    • Follicle-Stimulating Hormone (FSH): Stimulates the growth of ovarian follicles and the secretion of estrogen.

    • Luteal Hormone (LH): Triggers ovulation and the development of the corpus luteum.

  • Ovarian Hormones:

    • Estrogen: Responsible for secondary sex characteristics and thickening the endometrial lining.

    • Progesterone: Produced by the corpus luteum; maintains the endometrial lining for implantation and pregnancy.

Health History and Assessment
  • Obstetric History (GTPAL System):

    • G (Gravida): Total number of pregnancies.

    • T (Term): Number of pregnancies delivered at 3737 weeks or later.

    • P (Preterm): Number of pregnancies delivered between 2020 and 3636 weeks.

    • A (Abortion): Number of pregnancies ending before 2020 weeks (spontaneous or induced).

    • L (Living): Number of currently living children.

  • Menstrual History: Assess the interval between periods (normal is 213521-35 days) and the number of pads/tampons used per day to quantify blood loss.

Diagnostic Tests and Detailed Procedures
  • Papanicolaou (Pap) Smear: Screening for cervical cancer by scraping cells from the squamocolumnar junction.

    • Instruction: Advise the patient not to douche, use vaginal medications, or have intercourse for 244824-48 hours prior.

  • Hysterosalpingography: An X-ray with contrast to visualize the uterus and fallopian tubes to check for patency.

    • Nursing Alert: Assess for iodine or shellfish allergies before the procedure.

  • Mammography: Detection of microcalcifications.

    • Guidelines: Annual screenings starting at 404540-45 years old. Patients must avoid deodorant or powder, as these can appear as calcium deposits on the film.

  • Dilation and Curettage (D&C):

    • Used for diagnosis (endometrial tissue sampling) or treatment (managing incomplete miscarriage or polyps).

    • Post-op Care: Monitor for hemorrhage (check perineal pads) and vasovagal syncope.

Specific Reproductive Disorders
1. Infections and Inflammatory Conditions
  • Candidiasis (Yeast Infection): Characterized by a thick, white, "cottage cheese" discharge and intense pruritus. Treated with antifungal creams or oral fluconazole.

  • Trichomoniasis: A protozoan infection causing a malodorous, frothy, thin, yellow-green discharge and "strawberry cervix" (petechiae). Both partners must be treated with metronidazole.

  • Bacterial Vaginosis (BV): Overgrowth of anaerobic bacteria; presents with a fishy odor and thin grey-white discharge. Diagnosed via "clue cells" on a wet mount.

  • Pelvic Inflammatory Disease (PID):

    • Pathophysiology: Infection of the upper reproductive tract (uterus, tubes) usually caused by untreated Chlamydia or Gonorrhea.

    • Complications: Scars the fallopian tubes, leading to a high risk of ectopic pregnancy and chronic pelvic pain.

2. Endometriosis
  • Description: Functioning endometrial tissue grows outside the uterine cavity, responding to hormonal cycles by bleeding into the pelvic cavity.

  • Clinical Manifestations: Cyclical pelvic pain, infertility, and "chocolate cysts" (endometriomas) on the ovaries.

  • Management: NSAIDs for pain, oral contraceptives to suppress ovulation, or Lupron to induce a "pseudo-menopause" state.

3. Breast Cancer and Surgical Management
  • Types: Ductual Carcinoma in Situ (DCIS) or Infiltrating Ductal Carcinoma (most common).

  • Risk Factors: Early menarche (<12), late menopause (>55), nulliparity (no children), and BRCA11/BRCA22 gene mutations.

  • Nursing Care Post-Mastectomy:

    • Lymphedema Prevention: No BP, blood draws, or injections in the affected arm.

    • Elevation: Elevate the affected arm on pillows to promote lymphatic drainage.

    • Exercise: Encourage hand-squeezing and progressive arm exercises (e.g., "wall crawling").

4. Structural Abnormalities
  • Cystocele: Protrusion of the bladder into the vagina, often causing stress incontinence.

  • Rectocele: Protrusion of the rectum into the vagina, often causing constipation or a feeling of rectal pressure.

  • Intervention: Kegel exercises to strengthen pelvic floor muscles or surgical repair (Anterior/Posterior Colporrhaphy).

Advanced Nursing Considerations
  • Psychosocial Support: Issues involving the reproductive system often impact self-image, sexuality, and fertility. Provide a non-judgmental environment.

  • Hysterectomy Post-Op: Monitor for urinary retention (common after pelvic surgery) and assess for signs of Deep Vein Thrombosis (DVT) due to the lithotomy position used during surgery.

  • Education: Teach patients that douching is generally discouraged as it alters the pH and washes away protective lactobacilli, increasing infection risk.